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Editorial
A 
study is published reporting 
that a new drug works better in 
black people than in whites. Is 
this an informative study or is it based 
on archaic, incorrect, even harmful 
notions of human difference?
Homo sapiens has been called the 
species that names. An extensive 
literature reﬂ  ects millennia of concern 
over what we humans call ourselves 
and others. All life sciences are 
now grappling further with how to 
categorize and study the nearly inﬁ  nite 
polymorphisms within and among 
“species” as awareness grows that the 
species concept itself is inadequate. 
Human medicine, however, is in 
a unique position in that not only 
must it confront these problems of 
categorization that plague all life 
sciences, but this effort occurs in a 
complex sociopolitical context. As 
Smart and colleagues recently said, 
“One reason that race and ethnicity 
are difﬁ  cult concepts to operationalize 
or examine in scientiﬁ  c research is 
that they have meaning and usage that 
exists beyond the domain of scientiﬁ  c 
control” [1].
Dangers of Designations
In this issue of PLoS Medicine, Braun et 
al. [2] discuss some of the difﬁ  culties 
and dangers that go along with racial 
and ethnic designations in the clinic 
and in biomedical research. They 
propose that a clear consensus needs 
to be reached about exactly how to 
use race and ethnicity as variables and 
as designations and when it is valid 
to use them. They state further that 
while race may be used legitimately as 
a “descriptive” quality, it should not be 
used as a “biological attribution.” In 
other words, race as a social construct 
may result in differences in treatment 
that affect health outcomes, but such 
descriptive use does not imply that race 
can be used as a proxy for biological 
difference. In a commentary on the 
Fausto-Sterling essay, Ellison et al. 
[3] agree that standards of deﬁ  nition 
need to be improved, but caution that 
potentially important data may be at 
stake: citing the example of variance 
in histocompatibility antigen markers 
as important in transplantation 
research, they argue that variation in 
the frequency of genotypic markers 
among racial and ethnic groups 
should not be unilaterally discarded 
simply because of the risk that such 
information may be misused. They add 
that while international consensus on 
improved categorization is important, 
any guidelines deriving from such 
consensus will need to be made 
ﬂ  exible: “such categories cannot and 
should not be standardised for use 
in all scientiﬁ  c, social, and clinical 
contexts.” This proposal echoes a 
Nature Genetics editorial that argued 
for inclusion of multiple types of 
information (e.g., “ancestral and 
environmental”) so that the data can 
be “grouped ﬂ  exibly to serve the needs 
of medical geneticists, epidemiologists, 
and biological anthropologists” [4]. To 
complicate matters, a constraint facing 
many researchers is the requirement 
that US National Institutes of Health 
grantees in clinical research collect 
information on race that follows the 
current US census designations [5,6].
With this range of opinions, lack of 
unity and authority, and constraining 
rule from the largest granting agency in 
the US, the debate on whether and how 
to use race and ethnicity in biomedical 
research and its reporting seems almost 
intractable.
In journal publishing particularly, 
the need for clarity and guidance 
on how to deﬁ  ne and use race and 
ethnicity is increasing, especially over 
the last decade or so as the numbers of 
studies in two speciﬁ  c areas increase: 
genetic associations and studies of 
health inequities [7]. However, one 
analysis of a sample of 72 articles on 
cardiovascular disease reported that 
only 39 (55%) of articles referring 
to race/ethnicity described in detail 
how race/ethnicity was determined 
[8]. Further, a 2004 study of 120 
genetics and heredity journals found 
that only two included instructions to 
authors regarding race and ethnicity 
classiﬁ  cations [9]. Yet over half of 
the journals had published articles 
using racial or ethnic categories in the 
previous ten-year period. Even among 
journals with speciﬁ  c guidelines, 
adherence tends to be poor [7].
Solutions Are Possible
What can journals do? Should 
designations of race and ethnicity be 
left to an author’s discretion, since, 
after all, authors know the most about 
their own studies? Some editors have 
adopted such an approach, arguing 
that the author and referees are best 
equipped to offer expert guidance on 
the matter [1,9]. Other journals, instead 
of creating speciﬁ  c instructions for 
authors, have published position papers 
that seek to persuade, rather than 
force, authors to apply more consistent, 
rigorous standards of terminology and 
science (e.g., [10,11]). Kaplan and 
Bennett [11], for example, suggest that, 
whenever possible, studies of racial 
differences should include analyses to 
control or adjust for other variables, 
such as socioeconomic status, nutrition, 
environmental exposures, etc. (see also 
[12]). In 2004 Nature Genetics devoted 
an entire special issue (“Genetics for the 
Human Race”) to a discussion of how to 
conceptualize, deﬁ  ne, and study human 
racial and genetic differences (content 
freely available at http:⁄⁄www.nature.
com/ng/journal/v36/n11s/index.
html). As noted above, a few journals 
have added instructions or guidance 
to their author guidelines (e.g., Journal 
of the American Medical Association, http: 
⁄⁄jama.ama-assn.org/misc/ifora.dtl#
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ReportingRaceEthnicity; Canadian 
Medical Association Journal, http:⁄⁄www.
cmaj.ca/authors/policies.shtml; Genetics 
in Medicine, http:⁄⁄edmgr.ovid.com/
gim/accounts/ifauth.htm).
However helpful and forward-
thinking these individual journal 
responses are, community consensus 
would be more useful and authoritative. 
General scientiﬁ  c or medical editorial 
style guides have added useful detail 
and explanations to their chapters on 
terminology with each new edition 
[13,14]. A well-known example of 
community adoption of guidelines is 
of those produced by the International 
Committee of Medical Journal Editors 
(ICMJE, http:⁄⁄www.icmje.org/). Over 
600 journals (PLoS Medicine among 
them) have agreed to follow their 
Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals [15]. 
Regarding race and ethnicity (and 
by implication other categories), the 
guidelines state, “The guiding principle 
should be clarity about how and why 
a study was done in a particular way. 
When authors use variables such as 
race or ethnicity, they should deﬁ  ne 
how they measured the variables 
and justify their relevance” (section 
IV.A.6.a., Selection and Description 
of Participants [15]). Some authors 
feel, however, that while they provide a 
good foundation, these guidelines are 
not detailed or comprehensive enough 
[1,9,11].
A more detailed community 
consensus would provide the 
beneﬁ  ts of uniformity and legitimacy 
for both authors and editors. In 
addition to ICMJE, AMA (American 
Medical Association, http:⁄⁄www.
ama-assn.org/), and CSE (Council 
for Science Editors, http:⁄⁄www.
councilscienceeditors.org/), other 
organizations that might help develop 
such international consensus include 
WAME (World Association of Medical 
Editors, http:⁄⁄www.wame.org/) and 
EASE (European Association of Science 
Editors, http:⁄⁄www.ease.org.uk/).
More Than Race and Ethnicity
Although race and ethnicity as 
contentious variables in research 
and clinical medicine are the most 
discussed in the literature, they are not 
the only possible sources of incorrect 
generalizations and possibly harmful 
bias. Others are sex/gender, age, 
sexual orientation, disease/disability, 
religion, socioeconomic status, and 
many more. For example, the AMA 
Manual of Style (10th edition, section 
11.10 [13]) and the CSE manual (7th 
edition, section 7.5 [14]) offer advice 
on inclusive language in the areas of 
race/ethnicity, age, disease/disabilities, 
religion, and sexual orientation, 
emphasizing in part that terminology 
should be nonstigmatizing and 
reﬂ  ect the preferred designations of 
groups or individuals. In all of these 
areas humans have been subject to 
stereotyping and discrimination; thus a 
critical examination of all the names we 
call ourselves and others is warranted, 
and at least general guidelines should 
be developed for these areas, although 
consensus may take time.
Who Is Responsible?
Whose responsibility should it be 
to ensure that race, ethnicity, and 
other human variables are described 
appropriately? Authors and referees, 
who know their research and ﬁ  elds 
better than most journal editors do? Or 
editors, whose mandate it is to uphold 
the scientiﬁ  c and ethical quality of their 
journals? The answer is both, working 
collaboratively.
Ideally, authors would design their 
studies, including the reporting of 
studies, to the highest standards 
available at the time. Because those 
standards keep changing, however, 
editors can’t make authors go back 
in time and redesign a decades-
long prospective study to meet 
contemporary editorial standards. 
Editors should insist, however, 
that authors of studies based on 
different human categories should 
make their methods of categorizing 
human populations transparent, 
justify their study design, and control 
for confounding variables. And 
copyeditors can help by being well 
informed about current trends in 
usage, and should query authors about 
what, exactly, is meant by “black” or 
“homosexual” or “poor” or “elderly” 
when these designations are not clear, 
and recommend changing potentially 
offensive labels to more acceptable 
terminology (e.g., “diabetics” to 
“participants with diabetes”).
The biomedical landscape is 
becoming rapidly more complex. 
Burgeoning human genome and 
epidemiologic data, racially deﬁ  ned 
pharmaceutical treatments, and 
increased public concern over scientiﬁ  c 
research ethics combine to force 
everyone involved to confront the 
problems of deﬁ  ning and studying the 
causes and consequences of human 
differences. It is clear that although 
much can be done to improve clarity 
of reporting, race, ethnicity, religion, 
sex, sexual orientation, age, disease, 
disability, weight, and any of the 
multitude of other ways of categorizing 
humans are here to stay.  
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